DanCann Pharma, a Danish medical cannabis company, is issuing loan notes to an aggregate amount of DKK18.9m (US$2.9m) and 8,190,000 warrants to Nordic Growth Opportunities 2 (NGO2) in connection with…
DanCann Pharma, a Danish medical cannabis company, is issuing loan notes to an aggregate amount of DKK18.9m (US$2.9m) and 8,190,000 warrants to Nordic Growth Opportunities 2 (NGO2) in connection with…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference